News

All news

CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

CELLforCURE launches a process to find a buyer for its Les Ulis site

CELLforCURE, a subsidiary of the SEQENS Group, has informed its employee representatives of its decision to look for a potential buyer for its site in Les Ulis (Essonne). CELLforCURE specializes in the development and the contract manufacturing of Cell & Gene therapies.

Seqens women portraits: Juliette Martin, PhD

European Industry Summit: Pierre Luzeau, CEO of Seqens joins 73 industry leaders to call for a European Industrial Deal

Seqens and KK India petroleum specialties PVT LTD announce new partnership for lubricant additives in India

Products & Technologies

Skinification: plant polysaccharides rescue damaged hair

Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis

Seqens confirms the acquisition of CELLforCURE

New investments in China

Seqens group at DCAT Week 2023

Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston

SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory

Meeting with Virginie Tarlet for the International Women’s Day

Meeting with Yael Gofni for the International Women’s Day

1 2 3 4 5 … 7

Contact